Ocugen, Inc. — Director's Dealing 2020

Jan 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2020-01-02

Reporting Person: JORGENSEN DANIEL (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-02	Options (Right to Buy)	$.51	A	101470	Acquired	2030-01-02	Common Stock (101470)	Direct

Footnotes

F1: The options will vest annually in equal installments over three years commencing on January 2, 2021, subject to continued employment with the Company on the applicable vesting dates.